LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $59,000 | +195.0% | 680 | +423.1% | 0.00% | +100.0% |
| Q4 2021 | $20,000 | -39.4% | 130 | -39.5% | 0.00% | 0.0% |
| Q1 2021 | $33,000 | -31.2% | 215 | -55.8% | 0.00% | -50.0% |
| Q4 2020 | $48,000 | +77.8% | 486 | +73.0% | 0.00% | -33.3% |
| Q3 2020 | $27,000 | +200.0% | 281 | +123.0% | 0.00% | -25.0% |
| Q1 2020 | $9,000 | +800.0% | 126 | +740.0% | 0.00% | – |
| Q3 2019 | $1,000 | -75.0% | 15 | -55.9% | 0.00% | -100.0% |
| Q2 2019 | $4,000 | +300.0% | 34 | +385.7% | 0.00% | – |
| Q4 2018 | $1,000 | -92.3% | 7 | -94.4% | 0.00% | -100.0% |
| Q4 2016 | $13,000 | – | 124 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |